149 related articles for article (PubMed ID: 9511132)
1. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.
Buller JC; Kritz-Silverstein D; Barrett-Connor E; Wingard D
J Womens Health; 1998 Feb; 7(1):49-56. PubMed ID: 9511132
[TBL] [Abstract][Full Text] [Related]
2. Thiazide-associated metabolic abnormalities and estrogen replacement therapy: an epidemiological analysis of postmenopausal women in Rancho Bernardo, California.
Saxman KA; Barrett-Connor EL; Morton DJ
J Clin Endocrinol Metab; 1994 May; 78(5):1059-63. PubMed ID: 8175960
[TBL] [Abstract][Full Text] [Related]
3. Lower extremity arterial disease in older women: the Rancho Bernardo Study.
Yeh ST; Morton DJ; Barrett-Connor E
J Womens Health Gend Based Med; 2000 May; 9(4):373-80. PubMed ID: 10868609
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987.
Ferrara A; Barrett-Connor E; Wingard DL; Edelstein SL
Diabetes Care; 1995 Feb; 18(2):220-5. PubMed ID: 7729301
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein subclass distribution pattern and adiposity-associated dyslipidemia in postmenopausal women.
Maki KC; Davidson MH; Cyrowski MS; Maki AC; Marx P
J Am Coll Nutr; 2000 Feb; 19(1):23-30. PubMed ID: 10682872
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use.
von Muhlen D; Barrett-Connor E; Kritz-Silverstein D
Atherosclerosis; 2002 Mar; 161(1):209-14. PubMed ID: 11882334
[TBL] [Abstract][Full Text] [Related]
7. Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study).
von Mühlen D; Langer RD; Barrett-Connor E
Am J Cardiol; 2003 Jun; 91(11):1311-5. PubMed ID: 12767422
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
9. Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the Rancho Bernardo Study.
Kim DJ; Barrett-Connor E
Diabetes Care; 2006 Mar; 29(3):618-24. PubMed ID: 16505516
[TBL] [Abstract][Full Text] [Related]
10. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study.
Barrett-Connor E; Laughlin GA
Menopause; 2005; 12(1):40-8. PubMed ID: 15668599
[TBL] [Abstract][Full Text] [Related]
11. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
13. Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study.
Campos H; Wilson PW; Jiménez D; McNamara JR; Ordovas J; Schaefer EJ
Metabolism; 1990 Oct; 39(10):1033-8. PubMed ID: 2120547
[TBL] [Abstract][Full Text] [Related]
14. Employment status and heart disease risk factors in middle-aged women: the Rancho Bernardo Study.
Kritz-Silverstein D; Wingard DL; Barrett-Connor E
Am J Public Health; 1992 Feb; 82(2):215-9. PubMed ID: 1739150
[TBL] [Abstract][Full Text] [Related]
15. Effect of age on the exercise response in normal postmenopausal women during estrogen replacement therapy.
Seminario NA; Sciacca RR; DiTullio MR; Homma S; Giardina EG
J Womens Health Gend Based Med; 1999 Dec; 8(10):1273-9. PubMed ID: 10643835
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.
Wakatsuki A; Ikenoue N; Sagara Y
Maturitas; 1998 Jan; 28(3):229-34. PubMed ID: 9571598
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
18. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
Matthews KA; Kuller LH; Wing RR; Meilahn EN; Plantinga P
Am J Epidemiol; 1996 May; 143(10):971-8. PubMed ID: 8629615
[TBL] [Abstract][Full Text] [Related]
19. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
20. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study.
Green JS; Stanforth PR; Rankinen T; Leon AS; Rao Dc Dc; Skinner JS; Bouchard C; Wilmore JH
Metabolism; 2004 Sep; 53(9):1192-6. PubMed ID: 15334383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
